Mirae Asset Global Etfs Holdings Ltd. Caribou Biosciences, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 191,562 shares of CRBU stock, worth $398,448. This represents 0.0% of its overall portfolio holdings.
Number of Shares
191,562Holding current value
$398,448% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CRBU
# of Institutions
145Shares Held
53.7MCall Options Held
32.5KPut Options Held
89.8K-
Black Rock Inc. New York, NY6.95MShares$14.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.54MShares$9.45 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC4.16MShares$8.66 Million0.0% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA4.08MShares$8.49 Million0.34% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.62MShares$5.46 Million0.0% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $127M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...